A Study of BPI-460372 in Advanced Solid Tumor Patients

Clinical trial NCT05789602 · RECRUITING

Trial details

NCT number: NCT05789602
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-04-24
Primary completion: 2025-04-17
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.